Skip to main content
SpringerLink
Log in

Pharmacology of New Sleep-Improving Drugs

  • Conference paper
Neuropsychopharmacology

  • 63 Accesses

Abstract

Our modern way of life with its high levels of stress and anxiety has increased the salience of problems associated with insomnia and consequently also the search for drugs to alleviate this symptom. This review presents the most recent pharmacological data on two types of new sleep-improving drugs: (a) new hypnotics, which have proven active in humans, and (b) sleep modulators, which represent a speculative but interesting approach to the treatment of sleep disorders. We describe here compounds representative of each in terms of pharmacological profile and biochemical characteristics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bénavides J, Camelin JC, Mitrani N, Flamand F, Uzan A, Legrand JJ, Gueremy C, Le Fur G (1985) 2-amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission. II. Neuropharmacology 24: 1085–1092

    Article  PubMed  Google Scholar 

  • Billiard M, Besset A, De Lustrac C, Brissand L (1987) Dose-response effects of zopiclone on night sleep and on nightime and daytime functioning. Sleep 10 (suppl) 1: 27–34

    Google Scholar 

  • Blagoeva P, Masi I, Scotti de Carolis A, Longo VG (1972) Amino acid release from the cerebral cortex of the rabbit, its relationship with the electrocorticogram. Physiol Behav 9: 307–313

    Article  PubMed  CAS  Google Scholar 

  • Blanchard JC, Stutzmann JM (1988) Zopiclone (imovane) un nouvel hypnotique non benzodiazepinique: propriétés pharmacologiques et mecanisme d’action. Rev sci Méd 2: 65–81

    Google Scholar 

  • Blanchard JC, Boireaua, Garret C, Julou L (1979) In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors. Life Sci 24: 2417–2420

    Article  PubMed  CAS  Google Scholar 

  • Blanchard JC, Boireau A, Julou L (1983 a) Brain receptors and zopiclone. Pharmacology 27 (Suppl) 2: 59–69

    Article  CAS  Google Scholar 

  • Blanchard JC, Zundel JL, Julou L (1983 b) Differences between cyclopyrrolones (suriclone and zopiclone) and benzodiazepines binding to rat hippocampus photolabelled membranes. Biochem Pharmacol 32: 3651–3653

    Article  CAS  Google Scholar 

  • Braestrup C, Nielsen M (1981) [3H]Propyl β-carboline-3-carboxylate as a selective radioligand for the BZD1 benzodiazepine receptor subclass. J Neurochem 37: 333–341

    Google Scholar 

  • Chéramy A, Romo R, Godeheu G, Baruch P, Glowinski J (1986) In vivo presynaptic control of dopamine release in the cat caudate nucleus. II. Facilitory or inhibitory influence of L-glutamate. Neuroscience 19: 1081–1090

    Article  PubMed  Google Scholar 

  • Cook L, Davidson AB (1973) Effects of behaviourally active drugs in a conflict punishment procedure in rats. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 327–345

    Google Scholar 

  • Declerck AC, Wauquier PHM, Van der Ham-Veltman, Gelders Y (1987) Increase of slow wave sleep in human volunteers by the serotonin S2 2 2 2 2 2 2 antagonist ritanserin. Curr Ther Res 41: 427–432

    Google Scholar 

  • Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237: 649–658

    PubMed  CAS  Google Scholar 

  • Depoortere H, Decobert M, Riou-Merle F, Granger P (1988) Pharmaco-EEG profile of Zolpidem: an imidazopyridine hypnotic agent. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. Raven, New York, pp 81–96

    Google Scholar 

  • Disbrow JK, Ruth J A (1984) Differential glutamate release in brain regions of long sleep and short sleep mice. Alcohol 1: 201–203

    Article  PubMed  CAS  Google Scholar 

  • Doble A, Hubert JP, Perrier ML (1987) The pharmacology of an excitatory amino acid receptor. Br J Pharmacol 91: 23

    Google Scholar 

  • Dugovic C, Wauquier A (1987) 5-HT2 receptors could be primarily involved in the regulation of slow wave sleep in the rat. Eur J Pharmacol 137: 145–146

    Google Scholar 

  • Geller I, Seifter J (1960) The effects of meprobamate, barbiturates D-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacology 1: 482–492

    Article  CAS  Google Scholar 

  • Hollister LE (1973) Antianxiety drugs in clinical practice. In: Garettini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 367–377

    Google Scholar 

  • Idzikowski C, Mills FJ, Glennard R (1986) 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Res 378: 164–168

    Google Scholar 

  • Janssen PAJ (1988) The relevance of pharmacological studies to sleep research in psychiatry. Pharmacopsychiatry 21: 33–37

    Article  PubMed  CAS  Google Scholar 

  • Jasper H, Koyama I (1969) Rate of release of amino acids from the cerebral cortex in the cat affected by brainstem and thalamic stimulation. Can J Physiol Pharmacol 47: 889–905

    Article  PubMed  CAS  Google Scholar 

  • Jouvet M (1983) Mecanismes des etats de sommeil. In: Benoit O (ed) Physiologie du sommeil. Masson, Paris, pp 1–18

    Google Scholar 

  • Julou L, Bardone MC, Blanchard JC, Garret C, Stutzmann JM (1983) Pharmacological studies on zopiclone. Pharmacology 27: 46–58

    Article  PubMed  CAS  Google Scholar 

  • Julou L, Blanchard JC, Dreyfus JF (1985) Pharmacological and clinical studies of cy-clopyrrolones: zopiclone and suriclone. Pharmacol Biochem Behav 23: 653–659

    Article  PubMed  CAS  Google Scholar 

  • Klepner CA, Lippa AS, Benson DI, Sano MC, Beer B (1979) Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol Biochem Behav 11: 457–462

    Article  PubMed  CAS  Google Scholar 

  • Langer SZ, Arbilla S (1988) Limitations of the benzodiazepine receptor nomenclature: a proposal for a pharmacological classification as omega receptor subtypes. Fundam Clin Pharmacol 2: 159–170

    Article  PubMed  CAS  Google Scholar 

  • Langer SZ, Depoortere H, Sanger D, George P, Zivkovic B, Arbilla S, Lloyd KG, Bartholini G (1985) Biochemical and pharmacological profile of SL 80.0759–23 N, a new short acting hypnotic. J Neurochem 44: S179

    Google Scholar 

  • Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PFM, Laduron P (1985) Receptor-binding properties in vitro and in vivo of ritanserin. Mol Pharmacol 27: 600–611

    PubMed  CAS  Google Scholar 

  • Lippa AS, Jackson D, Wennogle LP, Beer B, Meyerson LR (1982) Non-benzodiazepine antagonists for benzodiazepine receptors. In: Usdin E, Skolnick P, Tallman JF, Greenblett D, Paul SM (eds) Pharmacology of benzodiazepines. MacMillan Press, London, pp 431 - 440

    Google Scholar 

  • Marks J (1980) The benzodiazepine use and abuse. Arzneimittelforschung/Drug Res 30: 388–390

    Google Scholar 

  • Michel F, Klein M, Jouvet D, Valatx JL (1961) Etude polygraphique du sommeil chez le rat. C R Soc Biol (Paris) 155: 2389–2392

    Google Scholar 

  • Mizoule J, Meldrum B, Mazadier M, Croucher M, Ollat C, Uzan A, Legrand JJ, Guérémy C, Le Fur G (1985) 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission. I. Anticonvulsant properties. Neuropharmacology 24: 767–773

    Article  PubMed  CAS  Google Scholar 

  • Möhler H, Okada T (1977) Benzodiazepine receptor: demonstration in the central nervous system. Science 198: 849–851

    Article  PubMed  Google Scholar 

  • Rataud J, Bardone MC, Stutzmann JM, Mazadier M, Uzan A, Blanchard JC, Laduron P (1988) Riluzole (PK 26124) induces discriminative stimuli in rats. Psychopharmacology 96 (Suppl): 373

    Google Scholar 

  • Radulovacki M, Virus RM, Djuricic-Nedelson M, Green RD (1983) Adenosine analogs and sleep in rats. J Pharmacol Exp Ther 228: 268–274

    Google Scholar 

  • Scatton B, Claustre Y, Dennis T, Nishikawa T (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines. J Pharmacol Exp Ther 237: 659–665

    PubMed  CAS  Google Scholar 

  • Schofield PR, Darlison MG, Fujita N, Burt DR, Stephenson FA, Rodriguez M, Rhee LM, Ramachadran J, Reale V, Glencorse TA, Seeburg PH, Barnard EA (1987) Sequence and functional expression of the GABAa receptor shows a ligand-gated receptor super-family. Nature 328: 221–227

    Article  PubMed  CAS  Google Scholar 

  • Snyder SH (1987) GABA-benzodiazepine receptor complex: focus on receptor subtypes and Cyclopyrrolone drugs. Isr J Med Sci 23: 145–152

    PubMed  CAS  Google Scholar 

  • Squires RF, Braestrup C (1977) Benzodiazepine receptor in rat brain. Nature 266: 732–734

    Article  PubMed  CAS  Google Scholar 

  • Stutzmann JM, Lucas M, Blanchard JC, Laduron PM (1988 a) Riluzole, a glutamate antagonist, enhances slow wave and REM sleep in rats. Neurosci Lett 88: 195–200

    Article  PubMed  CAS  Google Scholar 

  • Stutzmann JM, Laduron PM, Blanchard JC ( 1988 b) Sleep enhancing effect of riluzole in rats and cats. 9th European congress of sleep research, Jérusalem, Abstracts, p 207

    Google Scholar 

  • Zivkovic B, Perrault G, Morel E, Sanger DJ (1988) Comparative pharmacology of Zolpidem and other hypnotics and sleep inducers. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. Raven, New York, pp 97–110

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre de Recherches de Vitry, Rhône Poulenc Santé, 13 quai J. Guesde, 94403, Vitry Cedex, France

    J. C. Blanchard

Authors
  1. J. M. Stutzmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. M. Laduron
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. C. Blanchard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. College of Medicine, University of California at Irvine, 92717, Irvine, CA, USA

    W. E. Bunney Jr. M. D. (Professor of Psychiatry) (Professor of Psychiatry)

  2. Psychiatrische Klinik und Poliklinik, Universität München, Nußbaumstraße 7, 8000, München 2, Germany

    Hanns Hippius  & Gregor Laakmann  & 

  3. Bezirkskrankenhaus Augsburg, Dr.-Mack-Straße 1, 8900, Augsburg, Germany

    Max Schmauss

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Stutzmann, J.M., Laduron, P.M., Blanchard, J.C. (1990). Pharmacology of New Sleep-Improving Drugs. In: Bunney, W.E., Hippius, H., Laakmann, G., Schmauss, M. (eds) Neuropsychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74034-3_64

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74034-3_64

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74036-7

  • Online ISBN: 978-3-642-74034-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation